Dysfunctional Uterine Bleeding in Pediatrics 

  • Author: Germaine L Defendi, MD, MS, FAAP; Chief Editor: Andrea L Zuckerman, MD   more...
 
Updated: Jul 13, 2011
 

Background

Dysfunctional uterine bleeding (DUB) is classically defined as excessively heavy, prolonged, or frequent bleeding of uterine origin that is not caused by pregnancy or recognizable pelvic or systemic disease.[1, 2]

DUB usually results from disordered functioning of the hypothalamic-pituitary-ovarian (HPO) axis and is often associated with anovulatory cycles. The classic definition has proved less useful because of the current understanding of the pathophysiology of DUB. However, it does highlight that anovulatory uterine bleeding is a diagnosis of exclusion. DUB occurs most often in women at the extreme ends of their reproductive lifetime. Because premenarchal females have several anovulatory cycles per year, DUB is a common problem in adolescent females.[3, 4, 5]

The normal menstrual cycle, characterized by sequential growth, maturation, and eventual sloughing of the endometrial mucosa, is produced by the cyclic release of estrogen and progesterone from the ovary. This occurs (orchestrated by the HPO axis) with amazing regularity throughout most of a woman's reproductive lifetime. An understanding of the normal cyclic fluctuations of the 2 gonadotropins (ie, luteinizing hormone [LH], follicle-stimulating hormone [FSH]) and the primary female reproductive hormones (ie, estrogen, progesterone) helps clarify the derangements associated with anovulation.[6]

The first 14 days of a typical 28-day menstrual cycle (day 1 is defined as the first day of menstrual flow) are characterized by rising FSH levels, which stimulate ovarian follicle development and the subsequent production of estrogens (primarily estradiol). Serum progesterone levels are extremely low during this stage. LH levels climb more slowly but abruptly peak on day 12 or 13 in positive response to rising estrogen levels. See the image below.

The menstrual cycle. The menstrual cycle.

During that first 14 days, the endometrium, under the influence of estrogen, undergoes proliferation. The LH surge stimulates ovulation (on or about day 14) and conversion of the ovulatory follicle to a corpus luteum, which is responsible for estrogen and progesterone production. Under the influence of this progesterone, the endometrium is converted to a secretory state in preparation for implantation if fertilization of the ovum should occur. Progesterone is produced only if ovulation occurs. As LH levels drop (assuming fertilization and production of human chorionic gonadotropin [HCG] by the developing conceptus did not occur), the corpus luteum regresses, estrogen and progesterone levels plummet, and the endometrium deteriorates and is sloughed.

The average menstrual cycle is 28-29 days (range 21-35 d). Initially, some teenagers can have cycles as long as 45 days. Over time, the menstrual cycle becomes fairly consistent from month to month in any given woman. Normal menstrual flow lasts 7 or fewer days and produces an average total blood loss of 25-69 mL. Bleeding more frequently than every 21 days or less frequently than 45 days, menstrual flow longer than 7 days, and blood loss exceeding 80 mL are considered abnormal.

Next

Pathophysiology

With anovulation, estrogen levels rise as usual in the early phase of the cycle. In the absence of ovulation, a corpus luteum never forms and progesterone is not produced. The endometrium moves into a hyperproliferative state, ultimately outgrowing its estrogen supply. This leads to irregular sloughing of the endometrium and excessive bleeding from spiral arteries that have not undergone physiological senescence.

Previous
Next

Epidemiology

Frequency

United States

The exact incidence of DUB is unknown. The understanding of the epidemiology comes from case series reports from tertiary institutions with patients who are unlikely to reflect the general population. Nearly one half of all women have irregular periods in the first year after menarche, and over one half of the cycles are anovulatory. Irregular periods can persist for up to 5 years after menarche in 20% of women.

International

International rates should reflect those of the United States.

Mortality/Morbidity

The main complication of DUB is anemia.

  • Acute blood loss can occasionally lead to a profound anemia. Blood product transfusion (with the attendant risks and complications) is occasionally required.
  • Chronic or recurrent DUB can result in an iron-deficient state.
  • Blood loss in the healthy female adolescent is rarely of a fatal magnitude.

Race

Race does not seem to contribute significantly to the incidence of DUB.

Age

The average age of menarche in the United States is 12.3 years.[7] Irregular and anovulatory cycles may persist for as long as 1-5 years after the onset of menstrual periods.

Previous
 
 
Contributor Information and Disclosures
Author

Germaine L Defendi, MD, MS, FAAP  Associate Clinical Professor, Department of Pediatrics, Olive View-UCLA Medical Center

Germaine L Defendi, MD, MS, FAAP is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Specialty Editor Board

Elizabeth Alderman, MD  Director of Fellowship Training Program, Director of Adolescent Ambulatory Service, Professor of Clinical Pediatrics, Department of Pediatrics, Division of Adolescent Medicine, Albert Einstein College of Medicine and Children's Hospital at Montefiore

Elizabeth Alderman, MD is a member of the following medical societies: American Academy of Pediatrics, American Pediatric Society, North American Society for Pediatric and Adolescent Gynecology, and Society for Adolescent Medicine

Disclosure: Merck Honoraria Speaking and teaching

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Wayne Wolfram, MD, MPH  Associate Professor, Department of Emergency Medicine, Mercy St Vincent Medical Center

Wayne Wolfram, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Pediatrics, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Paul D Petry, DO, FACOP, FAAP  Consulting Staff, Freeman Pediatric Care, Freeman Health System

Paul D Petry, DO, FACOP, FAAP is a member of the following medical societies: American Academy of Osteopathy, American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association

Disclosure: Nothing to disclose.

Chief Editor

Andrea L Zuckerman, MD  Assistant Professor of Obstetrics/Gynecology and Pediatrics, Tufts University School of Medicine; Division Director, Pediatric and Adolescent Gynecology, Tufts Medical Center

Andrea L Zuckerman, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, Association of Professors of Gynecology and Obstetrics, Massachusetts Medical Society, North American Society for Pediatric and Adolescent Gynecology, and Society for Adolescent Medicine

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors Tod C Aeby, MD, and LeighAnn C Frattarelli, MD, MPH,to the development and writing of this article.

References
  1. Bravender T, Emans SJ. Menstrual disorders. Dysfunctional uterine bleeding. Pediatr Clin North Am. Jun 1999;46(3):545-53, viii. [Medline].

  2. Coupey SM, Ahlstrom P. Common menstrual disorders. Pediatr Clin North Am. Jun 1989;36(3):551-71. [Medline].

  3. Lavin C. Dysfunctional uterine bleeding in adolescents. Curr Opin Pediatr. Aug 1996;8(4):328-32. [Medline].

  4. Minjarez DA, Bradshaw KD. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am. Mar 2000;27(1):63-78. [Medline].

  5. Strickland J, Gibson EJ, Levine SB. Dysfunctional uterine bleeding in adolescents. J Pediatr Adolesc Gynecol. Feb 2006;19(1):49-51. [Medline].

  6. Collins J, Crosignani PG. Endometrial bleeding. Hum Reprod Update. Sep-Oct 2007;13(5):421-31. [Medline].

  7. Anderson SE, Must A. Interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of U.S. girls studied 10 years apart. J Pediatr. Dec 2005;147(6):753-60. [Medline].

  8. Austin SB, Ziyadeh NJ, Vohra S, Forman S, Gordon CM, Prokop LA. Irregular menses linked to vomiting in a nonclinical sample: findings from the National Eating Disorders Screening Program in high schools. J Adolesc Health. May 2008;42(5):450-7. [Medline].

  9. Toth M, Patton DL, Esquenazi B, Shevchuk M, Thaler H, Divon M. Association between Chlamydia trachomatis and abnormal uterine bleeding. Am J Reprod Immunol. May 2007;57(5):361-6. [Medline].

  10. National Heart Lung and Blood Institute (NHLBI). The Diagnosis, Evaluation and Management of von Willebrand Disease -- 2008 Clinical Practice Guidelines. National Institutes of Health. 2008;[Full Text].

  11. [Guideline] ACOG. Management of Anovulatory Bleeding. 2008 Compendium of Selected Publications. 2000;14:1049-56. [Full Text].

  12. Casablanca Y. Management of dysfunctional uterine bleeding. Obstet Gynecol Clin North Am. Jun 2008;35(2):219-34, viii. [Medline].

  13. Stabinsky SA, Einstein M, Breen JL. Modern treatments of menorrhagia attributable to dysfunctional uterine bleeding. Obstet Gynecol Surv. Jan 1999;54(1):61-72. [Medline].

  14. Rajput R, Dhuan J, Agarwal S, Gahlaut PS. Central venous sinus thrombosis in a young woman taking norethindrone acetate for dysfunctional uterine bleeding: case report and review of literature. J Obstet Gynaecol Can. Aug 2008;30(8):680-3. [Medline].

  15. Gultekin M, Diribas K, Buru E, Gökçeoglu MA. Role of a non-hormonal oral anti-fibrinolytic hemostatic agent (tranexamic acid) for management of patients with dysfunctional uterine bleeding. Clin Exp Obstet Gynecol. 2009;36(3):163-5. [Medline].

Previous
Next
 
The menstrual cycle.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.